Hepatocellular Carcinoma News and Research

RSS
Gene signature maps cholangiocarcinoma subtypes for precision treatment

Gene signature maps cholangiocarcinoma subtypes for precision treatment

Gut-derived metabolites regulate immune cells in complex ways

Gut-derived metabolites regulate immune cells in complex ways

New genetic ‘roadmap’ advances precision therapy for intrahepatic cholangiocarcinoma

New genetic ‘roadmap’ advances precision therapy for intrahepatic cholangiocarcinoma

Machine learning model predicts liver cancer risk with high accuracy

Machine learning model predicts liver cancer risk with high accuracy

Tiny gene mutations shape cancer behavior and immune response

Tiny gene mutations shape cancer behavior and immune response

Expert consensus validates UDFF for noninvasive fatty liver assessment

Expert consensus validates UDFF for noninvasive fatty liver assessment

New insight into origins of rare liver tumors in children

New insight into origins of rare liver tumors in children

EVA1A regulates fatty acid transporter CD36 in fatty liver disease

EVA1A regulates fatty acid transporter CD36 in fatty liver disease

Researchers develop new score to predict the risk of liver cancer

Researchers develop new score to predict the risk of liver cancer

University of Missouri launches first on-campus radiopharmaceutical clinical trial

University of Missouri launches first on-campus radiopharmaceutical clinical trial

Prognostic nutritional index proposed as prognostic marker in hepatocellular carcinoma

Prognostic nutritional index proposed as prognostic marker in hepatocellular carcinoma

Diagnostic prognostic and therapeutic relevance of PIVKA-II in hepatocellular carcinoma

Diagnostic prognostic and therapeutic relevance of PIVKA-II in hepatocellular carcinoma

Unraveling liver injury mechanisms in familial hypobetalipoproteinemia

Unraveling liver injury mechanisms in familial hypobetalipoproteinemia

Cigarette compound exposure drives sorafenib resistance in hepatocellular carcinoma

Cigarette compound exposure drives sorafenib resistance in hepatocellular carcinoma

Expert guidance on fecal microbiota transplantation in liver disease

Expert guidance on fecal microbiota transplantation in liver disease

Myosteatosis: An emerging predictor of outcomes in chronic liver disease

Myosteatosis: An emerging predictor of outcomes in chronic liver disease

NuSHs can be a promising therapeutic strategy for preventing MASH-related hepatocellular carcinoma

NuSHs can be a promising therapeutic strategy for preventing MASH-related hepatocellular carcinoma

A dual-action approach to preventing hepatocellular carcinoma

A dual-action approach to preventing hepatocellular carcinoma

Blocking liver enzyme Caspase-2 may increase long-term cancer risk

Blocking liver enzyme Caspase-2 may increase long-term cancer risk

Using contrast-enhanced ultrasound to distinguish hepatic PEComa from HCC without high-risk factors

Using contrast-enhanced ultrasound to distinguish hepatic PEComa from HCC without high-risk factors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.